SynthesisFrontiers in pharmacology2023

Cardiovascular benefits and safety of sotagliflozin in type 2 diabetes mellitus patients with heart failure or cardiovascular risk factors: a bayesian network meta-analysis.

Jiyifan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.